170 related articles for article (PubMed ID: 7636544)
1. B-cell lineage confers a favorable outcome among children and adolescents with large-cell lymphoma: a Pediatric Oncology Group study.
Hutchison RE; Berard CW; Shuster JJ; Link MP; Pick TE; Murphy SB
J Clin Oncol; 1995 Aug; 13(8):2023-32. PubMed ID: 7636544
[TBL] [Abstract][Full Text] [Related]
2. Clinical features and treatment outcome for children with CD30+ large-cell non-Hodgkin's lymphoma.
Sandlund JT; Pui CH; Santana VM; Mahmoud H; Roberts WM; Morris S; Raimondi S; Ribeiro R; Crist WM; Lin JS
J Clin Oncol; 1994 May; 12(5):895-8. PubMed ID: 8164039
[TBL] [Abstract][Full Text] [Related]
3. Large cell non-Hodgkin lymphoma of childhood: Analysis of 78 consecutive patients enrolled in 2 consecutive protocols at the Memorial Sloan-Kettering Cancer Center.
Mora J; Filippa DA; Thaler HT; Polyak T; Cranor ML; Wollner N
Cancer; 2000 Jan; 88(1):186-97. PubMed ID: 10618623
[TBL] [Abstract][Full Text] [Related]
4. Improved treatment outcome in Chinese children and adolescents with Burkitt's lymphoma and large cell lymphoma by using the modified B-non-Hodgkin's lymphoma-Berlin-Frankfurt-Münster-90 protocol.
Sun XF; Zhen ZJ; Lui DG; Xia Y; He YJ; Wang ZH; Lin JY; Guan ZZ
Eur J Haematol; 2006 Nov; 77(5):365-71. PubMed ID: 16879606
[TBL] [Abstract][Full Text] [Related]
5. Similar outcome of treatment of B-cell and T-cell diffuse large-cell lymphomas: the Stanford experience.
Kwak LW; Wilson M; Weiss LM; Doggett R; Dorfman RF; Warnke RA; Horning SJ
J Clin Oncol; 1991 Aug; 9(8):1426-31. PubMed ID: 1712837
[TBL] [Abstract][Full Text] [Related]
6. CD30-positive T-cell lymphomas co-expressing CD15: an immunohistochemical analysis.
Gorczyca W; Tsang P; Liu Z; Wu CD; Dong HY; Goldstein M; Cohen P; Gangi M; Weisberger J
Int J Oncol; 2003 Feb; 22(2):319-24. PubMed ID: 12527929
[TBL] [Abstract][Full Text] [Related]
7. Cd4+ T-cell immune response to large B-cell non-Hodgkin's lymphoma predicts patient outcome.
Ansell SM; Stenson M; Habermann TM; Jelinek DF; Witzig TE
J Clin Oncol; 2001 Feb; 19(3):720-6. PubMed ID: 11157023
[TBL] [Abstract][Full Text] [Related]
8. Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage--a report of the Berlin-Frankfurt-Münster Group.
Reiter A; Schrappe M; Parwaresch R; Henze G; Müller-Weihrich S; Sauter S; Sykora KW; Ludwig WD; Gadner H; Riehm H
J Clin Oncol; 1995 Feb; 13(2):359-72. PubMed ID: 7844597
[TBL] [Abstract][Full Text] [Related]
9. Among diffuse large B-cell lymphomas, T-cell-rich/histiocyte-rich BCL and CD30+ anaplastic B-cell subtypes exhibit distinct clinical features.
Maes B; Anastasopoulou A; Kluin-Nelemans JC; Teodorovic I; Achten R; Carbone A; De Wolf-Peeters C;
Ann Oncol; 2001 Jun; 12(6):853-8. PubMed ID: 11484964
[TBL] [Abstract][Full Text] [Related]
10. Treatment of pediatric B-cell non-Hodgkin's lymphomas at the Motol Hospital in Prague, Czech Republic: results based on the NHL BFM 90 protocols.
Kavan P; Kabickova E; Gajdos P; Koutecky J; Kodet R; McClain KL
Pediatr Hematol Oncol; 1999; 16(3):201-12. PubMed ID: 10326218
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of p80 and visceral involvement in childhood CD30 anaplastic large cell lymphoma (ALCL).
Massimino M; Spreafico F; Luksch R; Giardini R
Med Pediatr Oncol; 2001 Aug; 37(2):97-102. PubMed ID: 11496346
[TBL] [Abstract][Full Text] [Related]
12. [Comparison of the efficacy of CCCG-97 and BFM-90 protocols in the treatment for children with mature B-cell non-Hodgkin's lymphoma].
Meng JH; Gao YJ; Lu FJ; Zhai XW; Wang HS; Li J
Zhonghua Zhong Liu Za Zhi; 2012 Mar; 34(3):222-7. PubMed ID: 22780979
[TBL] [Abstract][Full Text] [Related]
13. Non-Hodgkin's lymphoma in adolescents: experiences in 378 adolescent NHL patients treated according to pediatric NHL-BFM protocols.
Burkhardt B; Oschlies I; Klapper W; Zimmermann M; Woessmann W; Meinhardt A; Landmann E; Attarbaschi A; Niggli F; Schrappe M; Reiter A
Leukemia; 2011 Jan; 25(1):153-60. PubMed ID: 21030984
[TBL] [Abstract][Full Text] [Related]
14. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
[TBL] [Abstract][Full Text] [Related]
15. CD30/Ki-1-positive lymphoproliferative disorders of the skin--clinicopathologic correlation and statistical analysis of 86 cases: a multicentric study from the European Organization for Research and Treatment of Cancer Cutaneous Lymphoma Project Group.
Paulli M; Berti E; Rosso R; Boveri E; Kindl S; Klersy C; Lazzarino M; Borroni G; Menestrina F; Santucci M
J Clin Oncol; 1995 Jun; 13(6):1343-54. PubMed ID: 7751878
[TBL] [Abstract][Full Text] [Related]
16. Primary Ki-1 anaplastic large-cell lymphoma in adults: clinical characteristics and therapeutic outcome.
Shulman LN; Frisard B; Antin JH; Wheeler C; Pinkus G; Magauran N; Mauch P; Nobles E; Mashal R; Canellos G
J Clin Oncol; 1993 May; 11(5):937-42. PubMed ID: 8387578
[TBL] [Abstract][Full Text] [Related]
17. Intensive chemotherapy without radiotherapy gives more than 85% event-free survival for non-Hodgkin lymphoma without central nervous involvement: a 6-year population-based study from the nordic society of pediatric hematology and oncology.
Márky I; Björk O; Forestier E; Jónsson OG; Perkkiö M; Schmiegelow K; Storm-Mathiesen I; Gustafsson G;
J Pediatr Hematol Oncol; 2004 Sep; 26(9):555-60. PubMed ID: 15342981
[TBL] [Abstract][Full Text] [Related]
18. Pathologic and clinical features of 77 Hodgkin's lymphoma patients treated in a lymphoma protocol (LNH87): a GELA study.
Cazals-Hatem D; André M; Mounier N; Copin MC; Divine M; Berger F; Bosly A; Kerneis Y; Brière J; Quesnel B; Diebold J; Gaulard P
Am J Surg Pathol; 2001 Mar; 25(3):297-306. PubMed ID: 11224599
[TBL] [Abstract][Full Text] [Related]
19. Clinical implications of serum levels of soluble CD30 in 70 adult anaplastic large-cell lymphoma patients.
Zinzani PL; Pileri S; Bendandi M; Buzzi M; Sabattini E; Ascani S; Gherlinzoni F; Magagnoli M; Albertini P; Tura S
J Clin Oncol; 1998 Apr; 16(4):1532-7. PubMed ID: 9552063
[TBL] [Abstract][Full Text] [Related]
20. T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases.
Coupland SE; Foss HD; Assaf C; Auw-Haedrich C; Anastassiou G; Anagnostopoulos I; Hummel M; Karesh JW; Lee WR; Stein H
Ophthalmology; 1999 Nov; 106(11):2109-20. PubMed ID: 10571346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
